Literature DB >> 5653816

Immunological enhancement by mouse isoantibodies: the importance of complement fixation.

T Chard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5653816      PMCID： PMC1409382     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  16 in total

1.  CHANGES IN THE HOST RESPONSE FOLLOWING TREATMENT WITH LYOPHILIZED TISSUE.

Authors:  S M CHANTLER; J R BATCHELOR
Journal:  Transplantation       Date:  1964-01       Impact factor: 4.939

2.  Immunological enhancement of a leukaemia.

Authors:  E A BOYSE; L J OLD; E STOCKERT
Journal:  Nature       Date:  1962-06-23       Impact factor: 49.962

3.  The antibody response to tumor inoculation; improved methods of antibody detection.

Authors:  P A GORER; Z B MIKULSKA
Journal:  Cancer Res       Date:  1954-10       Impact factor: 12.701

4.  Regression or survival of tumor homoiografts in mice pretreated with injections of lyophilized tissues.

Authors:  N KALISS
Journal:  Cancer Res       Date:  1952-05       Impact factor: 12.701

5.  Transplantation immunity: localization in mouse serum of antibodies responsible for haemagglutination, cytotoxicity and enhancement.

Authors:  G A Voisin; R G Kinsky; F K Jansen
Journal:  Nature       Date:  1966-04-09       Impact factor: 49.962

6.  Capacity of pepsin-digested antibody to inhibit antibody formation.

Authors:  T W Tao; J W Uhr
Journal:  Nature       Date:  1966-10-08       Impact factor: 49.962

7.  Loss of cytotoxicity of rabbit anti-Ehrlich ascites tumor cell antibody following pepsin digestion.

Authors:  F Whitehouse; J T Kilduff
Journal:  J Immunol       Date:  1966-09       Impact factor: 5.422

8.  Digestion of anti-kidney antibody: effects on its nephrotoxicity and ability to fix complement.

Authors:  P A Small; J H Baxter
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

9.  Enhancement of the C57BL leukemia E.L.4 by Fab fragments of isoantibody.

Authors:  T Chard; M E French; J R Batchelor
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

10.  Immunologic enhancement of sarcoma I by mouse gamma-globulin fractions.

Authors:  S Tokuda; F McEntee
Journal:  Transplantation       Date:  1967-07       Impact factor: 4.939
View more
  8 in total

1.  Fate of skin allografts in normal mice injected with antigraft strain globulin in relation to the IgG1 and IgG2 class of the antibodies.

Authors:  T N Harris; S Harris
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

2.  [Cytotoxic activity of guinea pig antibodies against BHK-cells inhibited by Fab-fragments].

Authors:  G Bandlow; M Partikel; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

3.  Effects of humoral and cellular immune reactions on tumor target cells in vitro. Their dependence on iso-, allo- or xenogenic origin of lymphocytes and antisera.

Authors:  H Warnatz; F Scheiffarth; J Rüters
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1973-05-07

4.  Suppression and enhancement of allografted tumour.

Authors:  M Yutoku; H Seno; Y Matsuoka; M Kitagawa
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

5.  The role of blocking antibodies in immunological enhancement.

Authors:  M Takasugi; E Klein
Journal:  Immunology       Date:  1971-10       Impact factor: 7.397

6.  Identification and characterization of guinea-pig antibodies that contrasensitize in mice.

Authors:  K Yonemasu; A J Crowle
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

7.  Immune status of mice tolerant of living cells. II. Continuous presence and nature of facilitation-enhancing antibodies in tolerant animals.

Authors:  G A Voisin; R G Kinsky; H T Duc
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

8.  Induction of plasminogen activator synthesis by antibodies.

Authors:  D Becker; L Ossowski; E Reich
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.